Journal
NATURE REVIEWS CANCER
Volume 15, Issue 4, Pages 216-224Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3912
Keywords
-
Categories
Funding
- Golfers Against Cancer
- Emerging Technology Fund of Texas [300-9-1958]
- Robert A. Welch Foundation [E-0004]
- Swedish Science Council
Ask authors/readers for more resources
Members of the nuclear receptor superfamily of ligand-dependent transcription factors carry out vital cellular functions and are highly druggable therapeutic targets. Liver X receptors (LXRs) are nuclear receptor family members that function in cholesterol transport, glucose metabolism and the modulation of inflammatory responses. There is now accumulating evidence to support the involvement of LXRs in a variety of malignancies and the potential efficacy of their ligands in these diseases. This Review summarizes the discovery and characterization of LXRs and their ligands, their effects and mechanisms in preclinical cancer models, and the future directions of basic and translational LXR research in cancer therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available